Proven Results
Proven Results That Accelerate Clinical Research
Our technology platform has demonstrated 94% faster enrollment timelines, 75% reduced screen failures, and 85% patient retention across 200+ clinical trials.
94%
Faster Enrollment
75%
Reduced Failures
85%
Patient Retention
200+
Trials Supported
PLATFORM IMPACT
10K+
Patients Enrolled
200+
Clinical Trials Supported
50+
Research Site Partners
94%
Faster Enrollment
(vs. traditional)
75%
Reduced Screen Failures
85%
Patient Retention
MIN
Avg Contact Time
(Not Days)
CASE STUDIES
Real results from real clinical trials
Case Study #1
ONCOLOGY TRIAL RESCUE
Phase II Breast Cancer Trial — Behind Timeline, At Risk of Cancellation
⚠ The Challenge
8 months behind enrollment timeline
Only 23 patients enrolled (target: 200)
$4.8M in delay penalties accumulating
Sites had exhausted patient databases
Sponsor considering trial cancellation
✓ Our Solution
Digital campaigns: Targeted Facebook, Instagram, and Google
Pre-screening: In-house team qualified every patient
Site coordination: Managed 12 sites in 6 states
Real-time analytics: Daily sponsor dashboard
★ The Results
147 patients in 4 months
Screen failure: 12% (vs. 48%)
$2.1M saved in penalties
Trial completed 3 months ahead
“Clinical Trial Solutions saved this trial. We went from considering cancellation to finishing early.”
— Sponsor Project Director
Case Study #2
FDA DIVERSITY MANDATE COMPLIANCE
Phase III Cardiovascular Trial — Hispanic Enrollment Required for Regulatory Approval
!
The Challenge
• Required 40% Hispanic enrollment per FDA mandate
• Current enrollment only 12% Hispanic
• Sites lacked Hispanic patient access
• Regulatory approval at stake
✓
Our Solution
Spanish-language campaigns: Full Spanish creative across TX, FL, CA, PR
Bilingual pre-screening: Native Spanish-speaking coordinators
Community partnerships: Hispanic health organizations
Demographic documentation: Detailed FDA tracking
FDA Diversity
12% → 44%
★ The Results
12%→44%
Hispanic Enrollment
6 wks
Early Completion
100%
FDA Requirements Met
Zero
Regulatory Delays
“Clinical Trial Solutions not only met our diversity requirement—they exceeded it. Their bilingual capabilities are the real deal.”
— CRO Diversity Lead
Case Study #3
RARE DISEASE RECRUITMENT
Phase I/II Genetic Disorder Trial — Ultra-Rare Population (<3,000 US Patients)
The Challenge
• Only ~3,000 diagnosed patients in entire US
• Needed 25 patients to meet enrollment
• Previous vendor failed to enroll a single patient in 6 months
• Complex eligibility with genetic confirmation required
Our Solution
Lookalike modeling: Custom audience based on condition-specific behaviors
Advocacy partnerships: Direct outreach through patient organizations
Nationwide reach: Telemedicine pre-screening removed geographic barriers
High-touch coordination: Dedicated coordinator for each patient
The Results
28 patients enrolled (exceeding 25-patient target)
40% lower cost-per-patient vs. industry benchmark
Enrollment completed in 5 months (vs. 18-month projection)
Zero dropout during treatment phase
Case Study #4
CNS/NEUROLOGY
MULTI-SITE COORDINATION
Phase III Alzheimer’s Trial — Complex Screening, High Dropout Risk
The Challenge
Industry-leading 70%+ screen failure rate for AD trials. Caregiver involvement required—double the coordination. 20 sites nationwide with inconsistent performance. Previous 35% dropout rate threatening data integrity.
Our Solution
Caregiver-focused campaigns: Targeted adult children researching parent’s condition. Extended pre-screening: 45-minute calls including cognitive pre-assessment. Dual coordination: Separate scheduling for patient and caregiver. Retention program: Weekly check-ins with both patient and caregiver.
38%
Screen Failure
(vs. industry 70%+)
12%
Dropout Rate
(vs. previous 35%)
100%
Timeline Met
(first time in portfolio)
9.2/10
Site Rating
(avg satisfaction)
Case Study #5
VACCINE TRIAL RAPID ENROLLMENT
Phase III Respiratory Vaccine — Urgent Timeline, High-Volume Requirement
Deadline
90 Days
!
The Challenge
• 500 patients needed in 90 days
• Specific age and health criteria
• Seasonal urgency—window closing
• Multiple competing trials
✓
Our Solution
High-volume campaigns: 2M+ impressions/week
Expanded call center: 500+ pre-screens/week
Site load balancing: Automated routing
Same-week scheduling: 72-hour booking
★
The Results
523 patients in 87 days
Seasonal window met
14% screen failure
22% under budget
THERAPEUTIC AREAS
Our platform has successfully recruited patients across all major therapeutic areas:
🎗️
Oncology
Breast, lung, prostate, melanoma, colorectal, leukemia, lymphoma, pancreatic, ovarian, brain tumors
❤️
Cardiovascular
Heart failure, hypertension, AFib, CAD, PAD, stroke prevention
🧠
Neurology/CNS
Alzheimer’s, Parkinson’s, MS, epilepsy, migraine, ALS, neuropathy
⚖️
Endocrinology
Type 1 & 2 diabetes, obesity, thyroid, NASH/NAFLD
🫁
Respiratory
Asthma, COPD, cystic fibrosis, pulmonary fibrosis
🧘
Mental Health
Depression, anxiety, PTSD, bipolar, schizophrenia, OCD, ADHD
✨
Dermatology
Psoriasis, eczema, vitiligo, acne, HS
🩺
Gastrointestinal
Crohn’s, ulcerative colitis, IBS, GERD, celiac
🧬
Rare Diseases
Genetic disorders, metabolic storage diseases, ultra-orphan conditions
💉
Vaccines
Respiratory, travel, HIV, hepatitis, infectious disease
Ready to See These Results on Your Trial?
Let’s discuss how our platform can accelerate your enrollment timeline.